Responses
British Paediatric Neurology Association and British Academy of Childhood Disability
G95 The Drooling Reduction Intervention (DRI) trial: Is hyoscine or glycopyrronium more effective and acceptable for the treatment of drooling in children with neurodisability?
Compose a Response to This Article
Other responses
No responses have been published for this article.